“…Several filter-based assays exploit the knowledge that most hematopoietic cells are smaller (<10 µm) than CTCs (>10 µm) [ 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 ]. A profusion of recently conceived microfluidic devices also uses the size and/or the deformability parameters [ 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ]. Finally, CTC isolation devices, many also being microfluidic-based [ 59 , 60 , 61 , 62 , 63 ], use dielectrophoresis (DEP) to differentiate tumor cells from normal cells by their electric charges [ 64 ].…”